Paper · 41127352
Sclerostin's role in bone-muscle crosstalk and osteoporosis pathogenesis.
Shahid H and 2 others. Osteoporos Sarcopenia, 2025. Cited by 9 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Sclerostin's role in bone-muscle crosstalk and osteoporosis pathogenesis. Papers, record 41127352. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41127352
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References173
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35,960,080 | Clinical application of bone turnover markers in treating osteoporotic vertebral compression fractures and their role in predicting fracture progression. | Medicine (Baltimore) | 2022 | https://conductscience.org/library/papers/35960080 | PubMed |
| 2 | 29,942,929 | Fibroblast Growth Factor 2 and Its Receptors in Bone Biology and Disease. | J Endocr Soc | 2018 | https://conductscience.org/library/papers/29942929 | PubMed |
| 3 | 33,531,538 | Effects of marathon race on selected myokines and sclerostin in middle-aged male amateur runners. | Sci Rep | 2021 | https://conductscience.org/library/papers/33531538 | PubMed |
| 4 | 33,634,128 | Running Against the Wnt: How Wnt/β-Catenin Suppresses Adipogenesis. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/33634128 | PubMed |
| 5 | 36,651,575 | Macrophages and Bone Remodeling. | J Bone Miner Res | 2023 | https://conductscience.org/library/papers/36651575 | PubMed |
| 6 | 21,617,991 | Sclerostin levels during growth in children. | Osteoporos Int | 2012 | https://conductscience.org/library/papers/21617991 | PubMed |
| 7 | 38,401,186 | Bone remodelling prediction using mechanical stimulus with bone connectivity theory in porous implants. | J Mech Behav Biomed Mater | 2024 | https://conductscience.org/library/papers/38401186 | PubMed |
| 8 | 31,921,183 | TNF-α Directly Enhances Osteocyte RANKL Expression and Promotes Osteoclast Formation. | Front Immunol | 2019 | https://conductscience.org/library/papers/31921183 | PubMed |
| 9 | 33,920,587 | The Potential of FGF-2 in Craniofacial Bone Tissue Engineering: A Review. | Cells | 2021 | https://conductscience.org/library/papers/33920587 | PubMed |
| 10 | 32,880,646 | Romosozumab: A first-in-class sclerostin inhibitor for osteoporosis. | Am J Health Syst Pharm | 2020 | https://conductscience.org/library/papers/32880646 | PubMed |
1 to 10 of 173
See all 173 referencesCited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,639,398 | The multisystem impact of perimenopausal hormonal fluctuations on chronic disease risk. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42639398 | PubMed |
| 42,403,364 | Periodontitis as a Model for Inflammatory Uncoupling of Bone Remodeling. | J Periodontal Res | 2026 | https://conductscience.org/library/papers/42403364 | PubMed |
| 42,323,687 | Irisin treatment counteracts bone loss and muscle atrophy in aged mice by reducing sclerostin expression in bone and skeletal muscle. | J Transl Med | 2026 | https://conductscience.org/library/papers/42323687 | PubMed |
| 42,121,850 | Osteocyte Mechanobiology in Peri-Implant Bone Adaptation: A Narrative Review and Hypothesis-Generating Framework for SOST/Wnt-Linked Cortical Stability. | Cells | 2026 | https://conductscience.org/library/papers/42121850 | PubMed |
| 42,036,678 | Pathophysiology and Molecular Signalling in Osteoporosis: Linking Risk Factors to Bone Loss. | J Cell Mol Med | 2026 | https://conductscience.org/library/papers/42036678 | PubMed |
| 41,752,899 | Real-World Assessment of Osteoporosis-Related Polymorphisms: Negative Findings for Osteoporosis and an Exploratory Association with Vitamin D. | Life (Basel) | 2026 | https://conductscience.org/library/papers/41752899 | PubMed |
| 41,596,293 | Osteoporosis After Menopause and After Drug Therapy: The Molecular Mechanism of Bone Loss and Its Treatment. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41596293 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| SOST | 50,964 | PubTator's text mining | https://conductscience.org/library/genes/50964 |
Source NCBI Gene
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41127352
GET https://conductscience.org/api/papers/v1/41127352/references?page=2